A Phase II, Single Arm, Multicentre Trial of Triamcinolone With a GnRH Analog for Castrate‐Resistant Prostate Cancer (TRICREST)Kenrick Ng, Jonathan Shamash, Shah‐Jalal Sarker et al.|The Prostate|2025Cited by 0